NEW peer reviewed evidence on the benefits of using CytoSorb Therapy in COVID-19 patients
- COVID-19
presented by Dr. Volker Humbert
- Continuous renal replacement therapy with the addition of CytoSorb cartridge in 50 critically ill patients with COVID-19 plus acute kidney injury: a case-series
- Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia
Share
|
NEW peer reviewed evidence on the benefits of using CytoSorb Therapy in COVID-19 patients
- November 23, 2020
- COVID-19
Share
|
presented by Dr. Volker Humbert
- Continuous renal replacement therapy with the addition of CytoSorb cartridge in 50 critically ill patients with COVID-19 plus acute kidney injury: a case-series
- Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia
More Videos
Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
Webinar | CytoSorb therapy in COVID-19 patients